Department of Internal Medicine , University of Texas Health Science Center , San Antonio , Texas , USA.
South Texas Research Institute , Edinburg , Texas , USA.
Hepatology. 2023 Jan 1;77(1):323-338. doi: 10.1002/hep.32542. Epub 2022 Nov 8.
Hepatocellular carcinoma (HCC) is a common cause of cancer-related mortality and morbidity worldwide. With the obesity pandemic, NAFLD-related HCC is contributing to the burden of disease exponentially. Genetic predisposition and clinical risk factors for NAFLD-related HCC have been identified. Cirrhosis is a well-known and major risk factor for NAFLD-related HCC. However, the occurrence of NAFLD-related HCC in patients without cirrhosis is increasingly recognized and poses a significant challenge regarding cancer surveillance. It is of paramount importance to develop optimal risk stratification scores and models to identify subsets of the population at high risk so they can be enrolled in surveillance programs. In this review, we will discuss the risks and prediction models for NAFLD-related HCC.
肝细胞癌(HCC)是全球癌症相关死亡率和发病率的常见原因。随着肥胖症的流行,非酒精性脂肪性肝病(NAFLD)相关 HCC 的发病率呈指数级增长。已经确定了与 NAFLD 相关 HCC 的遗传易感性和临床危险因素。肝硬化是非酒精性脂肪性肝病(NAFLD)相关 HCC 的一个众所周知的主要危险因素。然而,在没有肝硬化的患者中发生的 NAFLD 相关 HCC 越来越受到重视,并且对癌症监测构成了重大挑战。制定最佳风险分层评分和模型以识别高危人群亚组并将其纳入监测计划至关重要。在这篇综述中,我们将讨论与 NAFLD 相关 HCC 的风险和预测模型。